Literature DB >> 31332484

Functional characterization of a plant-produced infectious bursal disease virus antigen fused to the constant region of avian IgY immunoglobulins.

Emile Rage1, Charifa Drissi Touzani2, Carla Marusic1, Chiara Lico1, Thomas Göbel3, Alessio Bortolami4, Francesco Bonfante4, Anna Maria Salzano5, Andrea Scaloni5, Siham Fellahi2, Mohammed El Houadfi2, Marcello Donini6, Selene Baschieri1.   

Abstract

Infectious bursal disease virus (IBDV) is the cause of an economically important highly contagious disease of poultry, and vaccines are regarded as the most beneficial interventions for its prevention. In this study, plants were used to produce a recombinant chimeric IBDV antigen for the formulation of an innovative subunit vaccine. The fusion protein (PD-FcY) was designed to combine the immunodominant projection domain (PD) of the viral structural protein VP2 with the constant region of avian IgY (FcY), which was selected to enhance antigen uptake by avian immune cells. The gene construct encoding the fusion protein was transiently expressed in Nicotiana benthamiana plants and an extraction/purification protocol was set up, allowing to reduce the contamination by undesired plant compounds/proteins. Mass spectrometry analysis of the purified protein revealed that the glycosylation pattern of the FcY portion was similar to that observed in native IgY, while in vitro assays demonstrated the ability of PD-FcY to bind to the avian immunoglobulin receptor CHIR-AB1. Preliminary immunization studies proved that PD-FcY was able to induce the production of protective anti-IBDV-VP2 antibodies in chickens. In conclusion, the proposed fusion strategy holds promises for the development of innovative low-cost subunit vaccines for the prevention of avian viral diseases.

Entities:  

Keywords:  CHIR-AB1; Glycosylation; IBDV; IgY; Molecular farming; Veterinary vaccine

Year:  2019        PMID: 31332484     DOI: 10.1007/s00253-019-09992-9

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  2 in total

1.  Development of a Viral-Like Particle Candidate Vaccine Against Novel Variant Infectious Bursal Disease Virus.

Authors:  Yulong Wang; Nan Jiang; Linjin Fan; Li Gao; Kai Li; Yulong Gao; Xinxin Niu; Wenying Zhang; Hongyu Cui; Aijing Liu; Qing Pan; Changjun Liu; Yanping Zhang; Xiaomei Wang; Xiaole Qi
Journal:  Vaccines (Basel)       Date:  2021-02-10

2.  Development of a Novel Assay Based on Plant-Produced Infectious Bursal Disease Virus VP3 for the Differentiation of Infected From Vaccinated Animals.

Authors:  Alessio Bortolami; Marcello Donini; Carla Marusic; Chiara Lico; Charifa Drissi Touzani; Federica Gobbo; Elisa Mazzacan; Andrea Fortin; Valentina Maria Panzarin; Francesco Bonfante; Selene Baschieri; Calogero Terregino
Journal:  Front Plant Sci       Date:  2021-12-07       Impact factor: 5.753

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.